Current standards of care for melanoma excision in Australasia
Keith Monnington 1 3 * , Dirk Venter 2 3 *
+ Author Affiliations
- Author Affiliations
1 Skin Cancer College Australasia, PO Box 1604, Sunnybank Hills, Qld 4109, Australia.
2 Venter Medical Ltd, Auckland, New Zealand.
3 Corresponding authors. Email: keith@eol.co.nz; dirk.venter@icloud.com
Journal of Primary Health Care 11(3) 193-194 https://doi.org/10.1071/HC19071
Published: 30 September 2019
Journal Compilation © Royal New Zealand College of General Practitioners 2019 This is an open access article licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
References
[1] Tejera-Vaquerizo A, Russo F, Nieto-González G. Skin lesion suspicious of melanoma: time to one-step removal. J Prim Health Care. 2019; 11 87–8.| Skin lesion suspicious of melanoma: time to one-step removal.Crossref | GoogleScholarGoogle Scholar |
[2] Kelly JL, Beer T, Damian D. et al. Cancer Council Australia Melanoma Guidelines Working Party. What type of biopsy should be performed for a suspicious pigmented skin lesion? [https://wiki.cancer.org.au/australia/Clinical_question:What_type_of_biopsy_should_be_performed_for_a_suspicious_pigmented_skin_lesion%3F]. In: Cancer Council Australia Melanoma Guidelines Working Party. Clinical practice guidelines for the diagnosis and management of melanoma. Sydney: Cancer Council Australia. [cited 2019 July 24], Available from: https://wiki.cancer.org.au/australia/Guidelines:Melanoma
[3] Eggermont AMM, Blank CU, Mandela M, et al. Adjuvant Pembrolizumab versus Placebo in resected stage III melanoma. N Engl J Med. 2018; 378 1789–801.
| Adjuvant Pembrolizumab versus Placebo in resected stage III melanoma.Crossref | GoogleScholarGoogle Scholar | 29658430PubMed |
[4] Skin Cancer Audit and Research Database. SCARD v4.8.9 x64. [Cited 2019 July 24]. Available from: https://scard.skincanceraudit.com/reports/report-pool.php.
[5] Nelson KC, Swetter SM, Saboda K, et al. Evaluation of the number-needed-to-biopsy metric for the diagnosis of cutaneous melanoma: A systematic review and meta-analysis. JAMA Dermatol. 2019;
| Evaluation of the number-needed-to-biopsy metric for the diagnosis of cutaneous melanoma: A systematic review and meta-analysis.Crossref | GoogleScholarGoogle Scholar | 31290958PubMed |
